Your browser doesn't support javascript.
loading
Patient-reported Adverse Events During Neoadjuvant Therapy in a Phase 2 Borderline Resectable Pancreatic Cancer Clinical Trial (Alliance A021501).
Snyder, Rebecca A; Dueck, Amylou C; Fruth, Briant; Shi, Qian; Hubbard, Joleen M; Herman, Joseph M; O'Reilly, Eileen M; Katz, Matthew H G.
Afiliação
  • Snyder RA; Department of Surgical Oncology, The University of Texas at MD Anderson Cancer Center, Houston, TX.
  • Dueck AC; Department of Health Services Research, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Fruth B; Alliance Statistics and Data Center, Mayo Clinic, Scottsdale, AZ.
  • Shi Q; Alliance Statistics and Data Center, Mayo Clinic, Rochester, MN.
  • Hubbard JM; Alliance Statistics and Data Center, Mayo Clinic, Rochester, MN.
  • Herman JM; Department of Medical Oncology, Mayo Clinic, Rochester, MN.
  • O'Reilly EM; Northwell Health Cancer Institute, New Hyde Park, NY.
  • Katz MHG; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.
Ann Surg ; 278(4): 598-608, 2023 10 01.
Article em En | MEDLINE | ID: mdl-37334719
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Adenocarcinoma / Neoplasias Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Adenocarcinoma / Neoplasias Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article